| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 8 | 10 | 8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 8 |
| Expenses | 8 | 9 | 7 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 9 |
| EBITDA | 0 | 1 | 1 | -1 | -0 | 0 | -0 | -0 | -0 | -1 | -1 | -1 |
| Operating Profit % | 5 % | 5 % | 6 % | -57 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | -2 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | -2 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | -2 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 |
| EPS in ₹ | 0.16 | 0.06 | 0.30 | -5.37 | -0.38 | -0.14 | -0.41 | -0.42 | -0.77 | -1.68 | -0.99 | -0.90 |
Kabra Drugs
Kabra Drugs
20.72
+0.98
(4.96%)
Key Fundamentals
Market Cap
47.30 Cr
EPS
-0.99
PE Ratio
-47.02
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
22.77
52 Week Low
9.59
PB Ratio
1.99
Debt to Equity
0.08
Sector
Pharmaceuticals Actual
Company News
View All News
Kabra Drugs Limited has scheduled a Board of Directors meeting on October 8, 2025, to consider and approve the final draft of the Share Purchase Agreement for acquiring AMR PHARMA INDIA PRIVATE LIMITED. The meeting will also discuss broadening the board by bringing in new technical personnel. The board will authorize necessary steps to execute the agreement and complete the acquisition transaction.
Kabra Drugs Limited Reports Net Loss of Rs 49.98 Lacs in Q1 FY2026Aug 14, 2025
Kabra Drugs Limited reported a net loss of Rs 49.98 lacs for the quarter ended June 30, 2025, compared to a net profit of Rs 39.36 lacs in the same quarter of the previous year. The company's revenue from operations stood at Rs 715 lacs, while total expenses reached Rs 766.60 lacs. The Board of Directors approved these unaudited financial results at a meeting held on August 14, 2025. The company's earnings per share declined to negative Rs 0.21 from positive Rs 0.21 in the corresponding quarter last year. The company confirmed that Regulation 32 of SEBI (LODR) Regulations, 2015 regarding statement of deviation or variation is not applicable as it has not issued any shares through public issue, rights issue, or preferential issue.
Kabra Drugs Limited's Board of Directors approved the company's diversification into medical equipment and medical instruments. The company will establish a new office in Chennai at Cactus Corporate Coworking, Tecci Park, Sholinganallur, to support this new business venture. The board meeting was held on August 6, 2025, from 6:00 p.m. to 7:00 p.m.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,732.10 | #1 4,11,749.90 | 39.63 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 66.26 | |
6,520.00 | 1,73,603.20 | 69.64 | 9,712.00 | 18.67 | 2,191 | 35.10 | 50.59 | |
3,824.60 | 1,29,482.50 | 60.46 | 11,539.40 | 6.99 | 1,911 | 30.46 | 70.50 | |
1,519.30 | 1,22,366.70 | 22.59 | 28,409.50 | 7.12 | 5,291 | 3.71 | 44.46 | |
1,229.60 | 1,01,113.50 | #1 17.88 | 33,741.20 | 16.73 | 5,725 | -0.38 | 47.35 | |
951.40 | 94,475.30 | 19.03 | 23,511.00 | 18.55 | 4,615 | 34.60 | 39.39 | |
2,270.00 | 91,653.00 | 52.89 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.59 | |
2,033.90 | 90,250.10 | 21.39 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 62.84 | |
5,767.50 | 68,110.20 | 29.54 | 13,458.30 | 3.70 | 2,216 | 21.39 | 70.49 | |
1,183.60 | 67,849.20 | 20.35 | 32,345.60 | 9.43 | 3,484 | 3.81 | 67.18 |
Growth Rate
Revenue Growth
-
Net Income Growth
57.14 %
Cash Flow Change
-2,142.86 %
ROE
-93.53 %
ROCE
-93.53 %
EBITDA Margin (Avg.)
-100.00 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 9 | 9 | 6 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 25 |
| Fixed Assets | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6 | 6 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 5 | 25 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 6 | 6 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 5 | 25 |
| Total Liabilities | 9 | 9 | 6 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 25 |
| Current Liabilities | 3 | 4 | 3 | 2 | 1 | 1 | 2 | 1 | 1 | 4 | 1 |
| Non Current Liabilities | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 3 | 3 | 3 | 0 | 0 | 0 | -0 | -0 | -1 | 1 | 25 |
| Reserve & Surplus | -2 | -2 | -2 | -4 | -4 | -4 | -5 | -5 | -5 | -6 | 1 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 24 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 3 | 19 |
| Investing Activities | -0 | -0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Operating Activities | -0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -5 |
| Financing Activities | 1 | -0 | -0 | -1 | 0 | 0 | 0 | 0 | 0 | 3 | 23 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 92.21 % | 96.07 % | 96.08 % | 96.08 % | 96.12 % | 96.00 % | 96.09 % | 95.98 % | 95.97 % | 95.97 % | 95.95 % | 95.92 % | 95.73 % | 95.85 % | 96.19 % | 96.12 % | 95.94 % | 95.61 % | 95.00 % |
| Others | 7.79 % | 3.93 % | 3.92 % | 3.92 % | 3.88 % | 4.00 % | 3.91 % | 4.02 % | 4.03 % | 4.03 % | 4.05 % | 4.08 % | 4.27 % | 4.15 % | 3.81 % | 3.88 % | 4.06 % | 4.39 % | 5.00 % |
| No of Share Holders | 7,446 | 7,447 | 7,424 | 7,399 | 7,391 | 7,428 | 7,403 | 7,401 | 7,424 | 7,420 | 7,415 | 7,396 | 7,364 | 7,336 | 7,367 | 7,343 | 7,435 | 7,449 | 8,098 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Nov 2025 |  Quarterly Result Announcement | NA | 13 Nov 2025 | 19.25 | 19.74 |
| 02 Sept 2020 |  Change Of Name | NA | 02 Sept 2020 | 2.80 | 2.80 |
| 17 Feb 2024 |  Extraordinary General Meeting | NA | 17 Feb 2024 | 6.22 | 6.85 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 8.71 | 9.14 |
| 14 Nov 2024 | Quarterly Result Announcement | NA | 14 Nov 2024 | 9.14 | 9.59 |
| 02 Jan 2025 | Extraordinary General Meeting | NA | 02 Jan 2025 | 9.59 | 10.06 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 10.06 | 10.56 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 11.63 | 11.63 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 19.80 | 20.19 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 18.25 | 17.97 |
Announcements
Board Meeting Intimation for Intimation Of Board Meeting
7 days ago
7 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateOct 09, 2025
Oct 09, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Oct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateOct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorOct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 08, 2025
Oct 08, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 08 Th October 2025 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Oct 08, 2025
Oct 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Board Meeting Intimation for Intimation Board Meeting Of The Board Of DirectorsSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Sep 10, 2025Reg. 34 (1) Annual Report.Sep 09, 2025
Sep 09, 2025Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015Sep 06, 2025
Sep 06, 2025Book Closure And Schedule Of Events For E-Voting.Sep 03, 2025
Sep 03, 2025Appointment Of Secretarial AuditorSep 02, 2025
Sep 02, 2025Appointment Of Internal AuditorSep 02, 2025
Sep 02, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 02 Nd September 2025 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 02, 2025
Sep 02, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015Aug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 23, 2025
Aug 23, 2025Financial Results For The Quarter Ended June 30 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th August 2025 As Per Regulation 30 Of
SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Intimation Of Board MeetingAug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Aug 06, 2025
Aug 06, 2025Board Meeting Intimation for Board MeetingJul 31, 2025
Jul 31, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Board Meeting Outcome for Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI(Listing Obligations & Disclosure Requirements) Regulations 2015Jun 18, 2025
Jun 18, 2025Board Meeting Intimation for Intimation Of Proposed Board Meeting Of The Board Of DirectorsJun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 06, 2025
Jun 06, 2025Appointment Of Secretarial AuditorMay 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (LODR) Regulations 2015May 30, 2025
May 30, 2025Audited Financial Result For Quarter And Year Ended 31St March 2025 Pursuant To Regulation
33 Of The SEBI (LODR) Regulations 2015.May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI(Listing Obligations & Disclosure Requirements) Regulations 2015
May 30, 2025
May 30, 2025Board Meeting Intimation for Intimation Of Board MeetingMay 23, 2025
May 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2025
Apr 13, 2025Closure of Trading WindowMar 31, 2025
Mar 31, 2025Integrated Filing (Financial)Mar 03, 2025
Mar 03, 2025Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On December 31 2024.Feb 14, 2025
Feb 14, 2025Financial Results For The Quarter Ended December 31 2024 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Feb 14, 2025
Feb 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th February 2025 As Per Regulation 30 Of
SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 14, 2025
Feb 14, 2025Board Meeting Intimation for Intimation Of Board MeetingFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-AllotmentFeb 05, 2025
Feb 05, 2025Announcement under Regulation 30 (LODR)-AllotmentFeb 04, 2025
Feb 04, 2025Board Meeting Outcome for Outcome Of Meeting Of Allotment Committee Constituted By The Board Of Directors Of The Company.Feb 04, 2025
Feb 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 11, 2025
Jan 11, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 03, 2025
Jan 03, 2025Technical Indicators
RSI(14)
Neutral 57.24
ATR(14)
Less Volatile 1.07
STOCH(9,6)
Neutral 56.55
STOCH RSI(14)
Neutral 65.65
MACD(12,26)
Bullish 0.05
ADX(14)
Weak Trend 9.01
UO(9)
Bearish 52.81
ROC(12)
Uptrend And Accelerating 3.89
WillR(14)
Neutral -32.05
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
